Humana (NYSE:HUM) plans to cut a third of prior authorizations and refiles a case against the government over its 2025 Medicare Star Ratings cut. Read more here.

Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...